top of page
Screenshot 2024-08-26 at 11.46.23.png

At ViVerita
we develop the 
next wave of
precision therapies
by embracing the complexity and heterogeneity of cancer.

Gold Ribbon

Mission


Driven by patient needs, we confront cancer with precision and innovation. We discover novel therapeutic targets and develop transformative medicines that are effective, safe, and tailored for individual patients. We accomplish this through cutting-edge science and business excellence.

Vision

Studying cancer within physiologically relevant settings or “cancer in context” and developing innovative therapies to cure cancers and improve patient quality of lives.
Scientist with Test Tubes
Screenshot 2024-08-28 at 10.06.03.png

Approach

The parts of a sailboat only make sense in its native environment (i.e. in waters), where performance can be tested. Likewise, cancer as well as drug performance needs to be studied in its natural settings (i.e. in vivo).
 
ViVerita leverages a proprietary in vivo platform to empower the discovery of physiologically relevant targets and therapies to benefit cancer patients. 

Company

ViVerita Therapeutics has two sites.  It is headquartered in Boston, USA and has a wholly-owned subsidiary, ViVerita Discovery FlexCo, in Vienna, Austria. 


ViVerita Therapeutics focuses on drug development while ViVerita Discovery focuses on target identification and validation.

Unknown.jpeg
Tram in front of Burgtheater,  Vienna/Austria

Join the team

It takes an excellent team to create life-saving medicines. We are looking for talented, passionate, and team-oriented people to join us.  
 
If interested, please check out our open positions 

Contact
ViVerita Therapeutics

19 Freedom Farme Rd

Acton, MA 01720, USA 

USA

123-456-7890 

Thanks for submitting!

ViVerita Discovery

Karl-Farkas-Gasse 22

Cebina Incubator

1030 Vienna

Austria

123-456-7890 

Thanks for submitting!

bottom of page